Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3

被引：75

作者：

Boyd, Scott ^{[1
]}

Brookfield, Joanna L. ^{[2
]}

Critchlow, Susan E. ^{[1
]}

Cumming, Iain A. ^{[2
]}

Curtis, Nicola J. ^{[1
]}

Debreczeni, Judit ^{[1
]}

Degorce, Sebastien L. ^{[1
]}

Donald, Craig ^{[1
]}

Evans, Nicola J. ^{[3
]}

Groombridge, Sam ^{[1
]}

Hopcroft, Philip ^{[1
]}

Jones, Neil P. ^{[3
]}

Kettle, Jason G. ^{[1
]}

Lamont, Scott ^{[1
]}

Lewis, Hilary J. ^{[1
]}

MacFaull, Philip ^{[1
]}

McLoughlin, Sheila B. ^{[2
]}

Rigoreau, Laurent J. M. ^{[2
]}

Smith, James M. ^{[2
]}

St-Gallay, Steve ^{[1
]}

Stock, Julie K. ^{[3
]}

Turnbull, Andrew P. ^{[3
]}

Wheatley, Edward R. ^{[3
]}

Winter, Jon ^{[1
]}

Wingfield, Jonathan ^{[1
]}

机构：

[1] AstraZeneca, Oncol Innovat Med Unit, Macclesfield SK10 4TG, Cheshire, England

[2] CRT Discovery Labs, Cambridge CB22 3AT, England

[3] UCL, Wolfson Inst Biomed Res, CRT Discovery Labs, London WC1E 6BT, England

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 08期

关键词：

KEY GLYCOLYTIC ENZYME; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; CANCER; PHOSPHOFRUCTOKINASE; EXPRESSION; FAMILY;

D O I：

10.1021/acs.jmedchem.5b00352

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A weak screening hit with suboptimal physicochemical properties was optimized against PFKFB3 kinase using critical structure-guided insights. The resulting compounds demonstrated high selectivity over related PFKFB isoforms and modulation of the target in a cellular context. A selected example demonstrated exposure in animals following oral dosing. Examples from this series may serve as useful probes to understand the emerging biology of this metabolic target.

引用

页码：3611 / 3625

页数：15

共 50 条

[31] Structure-based design of a potent and selective peptide inhibitor of caspase-3
Yoshimori, A
Takasawa, R
Sakai, J
Kobayashi, T
Sunaga, S
Tanuma, SI
FEBS JOURNAL, 2005, 272 : 523 - 523
[32] Structure-Based Design of Potent and Selective 2-(Quinazolin-2-yl)phenol Inhibitors of Checkpoint Kinase 2
Caldwell, John J.
Welsh, Emma J.
Matijssen, Cornelis
Anderson, Victoria E.
Antoni, Laurent
Boxall, Kathy
Urban, Frederique
Hayes, Angela
Raynaud, Florence I.
Rigoreau, Laurent J. M.
Raynham, Tony
Aherne, G. Wynne
Pearl, Laurence H.
Oliver, Antony W.
Garrett, Michelle D.
Collins, Ian
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (02) : 580 - 590
[33] Structure-based drug design of pyruvate kinase inhibitors
Maxwell, David S.
Peng, Zhenghong
Sun, Duoli
Yung, W. K. Alfred
Lu, Zhimin
Bornmann, William G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[34] Structure-based development of potent and selective type-II kinase inhibitors of RIPK1
Qin, Ying
Li, Dekang
Qi, Chunting
Xiang, Huaijiang
Meng, Huyan
Liu, Jingli
Zhou, Shaoqing
Gong, Xinyu
Li, Ying
Xu, Guifang
Zu, Rui
Xie, Hang
Xu, Yechun
Xu, Gang
Zhang, Zheng
Chen, Shi
Pan, Lifeng
Li, Ying
Tan, Li
ACTA PHARMACEUTICA SINICA B, 2024, 14 (01) : 319 - 334
[35] Structure-based design of potent and selective DLG-out RIPK1 inhibitors
Suebsuwong, Chalada
Najjar, Malek
Ray, Soumya
Thapa, Roshan
Maki, Jenny
Nogusa, Shoko
Shah, Saumil
Saleh, Danish
Gough, Peter
Bertin, John
Yuan, Junying
Balachandran, Siddharth
Cuny, Gregory
Degterev, Alexei
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[36] Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors
Cheng, Hengmiao
Li, Puhui
Chen, Ping
Irimia, Adriana
Bae, Jae Hyun
Brooun, Alexei
Fagan, Patrick
Lam, Richard
Lin, Bingzhen
Zhang, Jingchuan
Zhan, Xuejun
Wu, Xu
Xie, Nan
Chiang, Gary
Shoemaker, Robert
Vernier, Jean-Michel
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (10): : 1351 - 1357
[37] Structure-based design of novel potent nonpeptide thrombin inhibitors
Hauel, NH
Nar, H
Priepke, H
Ries, U
Stassen, JM
Wienen, W
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (09) : 1757 - 1766
[38] Structure-based design and optimization of potent inhibitors of the adenoviral protease
Grosche, Philipp
Sirockin, Finton
Mac Sweeney, Aengus
Ramage, Paul
Erbel, Paul
Melkko, Samu
Bernardi, Anna
Hughes, Nicola
Ellis, David
Combrink, Keith D.
Jarousse, Nadine
Altmann, Eva
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (03) : 438 - 443
[39] Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors
Waldschmidt, Helen V.
Homan, Kristoff T.
Cruz-Rodriez, Osvaldo
Cato, Marilyn C.
Waninger-Saroni, Jessica
Larimore, Kelly M.
Cannavo, Alessandro
Song, Jianliang
Cheung, Joseph Y.
Kirchhoff, Paul D.
Koch, Walter J.
Tesmer, John J. G.
Larsen, Scott D.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (08) : 3793 - 3807
[40] Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors
Li, Gudong
Zhang, Wei
Xie, Yuting
Li, Yang
Cao, Rao
Zheng, Guojun
Huang, Niu
Zhou, Yu
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (06) : 3287 - 3294

← 1 2 3 4 5 →